comparemela.com
  1. Home
  2. Live Updates
  3. பொருள் நிபுணர் குழு - Breaking News

பொருள் நிபுணர் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ampio Pharma bags DCGI approval for AP-019 Phase II Study on covid

Ampio Pharma bags DCGI approval for AP-019 Phase II Study on covid
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Mike macalusoAmpio pharmaceuticalsExpert committeeCentral drugs standard control organizationDrugs controller generalSubject expert committeeமைக் மக்ளுஸோநிபுணர் குழுமைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்துகள் கட்டுப்படுத்தி ஜநரல்பொருள் நிபுணர் குழு

DCGI approves use of inhaled Ampion for COVID-19-related respiratory distress

DCGI approves use of inhaled Ampion for COVID-19-related respiratory distress
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Ampio pharmaceuticalsExpert committeeCentral drugs standard control organizationDrugs controller generalSubject expert committeeநிபுணர் குழுமைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்துகள் கட்டுப்படுத்தி ஜநரல்பொருள் நிபுணர் குழு

Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India

Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKatie kennedyMike macalusoExchange commissionAmpio pharmaceuticalsCentral drugs standard control organizationExpert committeeAmpio pharmaceuticals incDrugs controller generalSubject expert committeeMiddle eastBiologics price competitionInnovation actPrivate securities litigation reform actBiological license applicationAnnual report

Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India

Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKatie kennedyMike macalusoExchange commissionAmpio pharmaceuticalsCentral drugs standard control organizationExpert committeeAmpio pharmaceuticals incDrugs controller generalSubject expert committeeMiddle eastBiologics price competitionInnovation actPrivate securities litigation reform actBiological license applicationAnnual report

WHO emergency use authorisation to Covaxin delayed till October 5

WHO emergency use authorisation to Covaxin delayed till October 5
newsx.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsx.com Daily Mail and Mail on Sunday newspapers.

Hanna nohynekNational institute of virologyStrategic advisory group of experts on immunizationApplication to world health organizationUn public health agencyIndian council of medical researchCentral drugs standard control organisationWorld health organisationExpert committeeHyderabad based bharat biotechStrategic advisory groupWorking groupBharat biotechEmergency use listingWorld health organizationSubject expert committee

vimarsana © 2020. All Rights Reserved.